Published in Eur J Nucl Med Mol Imaging on June 01, 2005
Simultaneous mapping of pan and sentinel lymph nodes for real-time image-guided surgery. Theranostics (2014) 0.98
The sentinel node in breast cancer. Cancer Imaging (2008) 0.80
The role of preoperative lymphoscintigraphy in surgery planning for sentinel lymph node biopsy in malignant melanoma. Wien Klin Wochenschr (2006) 0.79
Sentinel lymph node scintigraphy in cutaneous melanoma using a planar calibration phantom filled with Tc-99m pertechnetate solution for body contouring. Clujul Med (2016) 0.75
The sentinel node in breast cancer: an update. Cancer Imaging (2005) 0.75
Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg (1992) 9.97
Management of cutaneous melanoma. N Engl J Med (2004) 9.52
Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol (1999) 3.74
Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. Eur J Surg Oncol (2004) 3.00
Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol (2000) 1.92
The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg (2004) 1.87
High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma. Br J Surg (2004) 1.46
Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg (2001) 1.36
The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Cancer (2001) 1.25
Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease. Eur J Cancer (2004) 1.14
Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol (2003) 1.11
Sentinel lymphadenectomy for patients with clinical stage I melanoma. J Surg Oncol (1997) 1.11
Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol (2003) 1.06
Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol (1991) 1.02
Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med (1999) 0.97
Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: is it standard of care? J Am Coll Surg (1999) 0.86
Consequences of axillary recurrence after conservative breast surgery. Br J Surg (2002) 0.86
Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis. J Surg Oncol (2004) 0.83
Gamma probe guided biopsy of the sentinel node in malignant melanoma: a multicentre study. Melanoma Res (2001) 0.82
Sensitivity of sentinel node biopsy in melanoma. J Surg Oncol (2001) 0.81
Summary of the Second International Sentinel Node Conference. Eur J Nucl Med (2001) 0.75
The sentinel node procedure in patients with melanoma. Eur J Surg Oncol (2004) 0.75
Lymphatic mapping and selective lymphadenectomy for melanoma: not yet standard therapy. Eur J Surg Oncol (1997) 0.75
Melanoma: questions for the future. Eur J Surg Oncol (1996) 0.75
Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med (2006) 15.64
Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med (2014) 10.69
Sentinel node biopsy and standard of care for melanoma. J Am Acad Dermatol (2009) 4.32
Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg (2005) 3.80
The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol (2010) 3.02
Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. J Clin Oncol (2011) 2.62
Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma. Eur Urol (2007) 2.44
The EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging (2013) 2.25
Anatomical mapping of lymphatic drainage in penile carcinoma with SPECT-CT: implications for the extent of inguinal lymph node dissection. Eur Urol (2008) 2.19
Early assessment of axillary response with ¹⁸F-FDG PET/CT during neoadjuvant chemotherapy in stage II-III breast cancer: implications for surgical management of the axilla. Ann Surg Oncol (2013) 2.08
Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Ann Surg Oncol (2006) 2.00
Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy. Ann Surg Oncol (2006) 1.95
The yield of SPECT/CT for anatomical lymphatic mapping in patients with melanoma. Ann Surg Oncol (2009) 1.93
Metastasectomy for distant metastatic melanoma: analysis of data from the first Multicenter Selective Lymphadenectomy Trial (MSLT-I). Ann Surg Oncol (2012) 1.92
Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma. Eur Urol (2009) 1.71
Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients. J Clin Oncol (2005) 1.70
EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging (2009) 1.68
Nodal staging in penile carcinoma by dynamic sentinel node biopsy after previous therapeutic primary tumour resection. Eur Urol (2010) 1.55
Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT. J Nucl Med (2012) 1.53
Lymphatic drainage patterns from the breast. Ann Surg (2004) 1.53
Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma. Ann Surg Oncol (2004) 1.51
Combined use of ¹⁸F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy. Eur J Nucl Med Mol Imaging (2014) 1.49
Accuracy of internal mammary lymph node localization using lymphoscintigraphy, sonography and CT. Radiother Oncol (2002) 1.45
Comparison of three micromorphometric pathology classifications of melanoma metastases in the sentinel node. Ann Surg (2009) 1.44
Size of metastasis in the sentinel node predicts additional nodal involvement in penile carcinoma. J Urol (2006) 1.43
Lymphatic mapping in patients with breast carcinoma: reproducibility of lymphoscintigraphic results. Radiology (2003) 1.43
Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer. J Surg Oncol (2006) 1.43
Feasibility of sentinel node lymphoscintigraphy in stage I testicular cancer. Eur J Nucl Med Mol Imaging (2002) 1.42
Radionuclide therapy in oncology: the dawning of its concomitant use with other modalities? Eur J Nucl Med Mol Imaging (2004) 1.41
Evaluation of (18)F-FDG PET-CT for differentiation of pulmonary pathology in an approach of outpatient fast track assessment. J Thorac Oncol (2009) 1.41
Significance of serum S-100B in melanoma patients before and after sentinel node biopsy. J Surg Oncol (2005) 1.40
Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECT/CT. J Nucl Med (2009) 1.33
Tumor response and toxicity of neoadjuvant erlotinib in patients with early-stage non-small-cell lung cancer. J Clin Oncol (2012) 1.28
Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer. Ann Surg Oncol (2011) 1.25
Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol (2003) 1.20
131I-MIBG therapy in metastatic phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging (2007) 1.18
SPECT/CT for preoperative sentinel node localization. J Surg Oncol (2010) 1.17
Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-(99m)Tc-nanocolloid. Eur J Nucl Med Mol Imaging (2012) 1.15
Two-center evaluation of dynamic sentinel node biopsy for squamous cell carcinoma of the penis. J Clin Oncol (2009) 1.11
Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol (2003) 1.11
In vivo imaging of radiation-induced apoptosis in follicular lymphoma patients. Int J Radiat Oncol Biol Phys (2004) 1.08
Assessment of lymphatic drainage patterns and implications for the extent of neck dissection in head and neck melanoma patients. J Surg Oncol (2011) 1.07
The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. J Nucl Med (2007) 1.06
The Hybrid SPECT/CT as an additional lymphatic mapping tool in patients with breast cancer. World J Surg (2008) 1.02
18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques. Breast Cancer Res Treat (2011) 1.00
SPECT-CT and real-time intraoperative imaging: new tools for sentinel node localization and radioguided surgery? Eur J Nucl Med Mol Imaging (2009) 1.00
Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes. Cancer (2006) 1.00
Lymphatic drainage patterns from the treated breast. Ann Surg Oncol (2009) 0.99
A portable gamma-camera for intraoperative detection of sentinel nodes in the head and neck region. J Nucl Med (2010) 0.98
99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging (2007) 0.98
FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer. Breast (2013) 0.97
Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities. Cancer (2003) 0.96
Ultrasonography-guided fine-needle aspiration cytology before sentinel node biopsy in patients with penile carcinoma. BJU Int (2005) 0.96
Utility of preoperative 18F-FDG PET/CT and brain MRI in melanoma patients with palpable lymph node metastases. Ann Surg Oncol (2010) 0.96
The additional value of lymphatic mapping with routine SPECT/CT in unselected patients with clinically localized melanoma. Ann Surg Oncol (2011) 0.94
Ultrasonography and fine-needle aspiration cytology in the preoperative evaluation of melanoma patients eligible for sentinel node biopsy. Ann Surg Oncol (2006) 0.92
99mTc-HYNIC-rh-annexin-V scintigraphy: visual and quantitative evaluation of early treatment-induced apoptosis to predict treatment outcome. Nucl Med Commun (2008) 0.92
T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy. Clin Cancer Res (2011) 0.92
Dynamic sentinel node biopsy in penile carcinoma: evaluation of 10 years experience. Eur Urol (2005) 0.92
Technological innovation in the sentinel node procedure: towards 3-D intraoperative imaging. Eur J Nucl Med Mol Imaging (2010) 0.91
Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients. Eur J Cancer (2005) 0.91
Heading toward radioactive seed localization in non-palpable breast cancer surgery? A meta-analysis. J Surg Oncol (2014) 0.90
The yield of SPECT/CT for anatomical lymphatic mapping in patients with breast cancer. Eur J Nucl Med Mol Imaging (2009) 0.90
Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J Nucl Med (2009) 0.90
Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients. J Nucl Med (2012) 0.90
Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy. Breast Cancer Res Treat (2012) 0.89
Dilemma of clinically node-negative head and neck melanoma: outcome of "watch and wait" policy, elective lymph node dissection, and sentinel node biopsy--a systematic review. Head Neck (2008) 0.88
Targeted non-covalent self-assembled nanoparticles based on human serum albumin. Biomaterials (2011) 0.88
Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer. Acta Oncol (2013) 0.87